NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.500
+0.002 (0.13%)
Feb 11, 2026, 12:56 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 167.09 million as of February 11, 2026. Its market cap has decreased by -8.56% in one year.
Market Cap
167.09M
Enterprise Value
128.37M
Revenue
11.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 167.09M, an increase of 405.93%. That is a compound annual growth rate of 20.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 167.09M | 105.20% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 247.53M |
| Magle Chemoswed Holding AB | 237.47M |
| AlzeCure Pharma AB | 218.34M |
| Xbrane Biopharma AB | 214.30M |
| Initiator Pharma | 205.36M |
| Sprint Bioscience AB | 195.20M |
| Karolinska Development AB | 189.33M |
| Isofol Medical AB | 165.29M |